News and Trends 15 Jul 2022
Triastek forms pact with Eli Lilly to 3D print tablets for oral drug delivery
A new research collaboration between Triastek, Inc. and Eli Lilly and Company will leverage 3D printing technology to achieve precise targeting and programmed drug release in the intestine. The China-based Triastek has developed proprietary 3D printing technology that provides solutions for drug development. According to the agreement, Triastek and Lilly will focus on improving the […]